Physician profile
Muhammad Khan
NPI 1861927386
$12,585.25
in general payments reported to CMS, 2019-2025
9 companies · $6,292 in 2025
The $6,292 reported for 2025 was more than what 82% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $75.06 · 2023: $1,682 · 2024: $4,536 · 2025: $6,292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,430 · Travel and Lodging: $5,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,429.98 |
| Travel and Lodging | $5,080.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,403.67 | 2022-2025 | Surpass Evolve, Target, Evolve |
| Medtronic, INC. | $1,878.36 | 2023-2025 | Pipeline, Axium Primetm, Rist |
| Imperative Care, INC | $1,601.06 | 2024-2025 | Zoom Reperfusion Catheter, Zoom 88-T Large Distal Platform |
| Qapel Medical INC | $1,196.70 | 2024 | |
| Balt USA, LLC | $927.15 | 2024-2025 | Optima Coil System, Prestige Coil System, Carrier Delivery Catheter |
| Penumbra, INC. | $277.11 | 2025 | Penumbra System, Red 72 |
| Rapid Medical LTD | $241.06 | 2025 | Comaneci 17, Tigertriever 17 Revascularization Device |
| Scientia Vascular | $35.72 | 2023 | |
| Siemens Medical Solutions USA, INC. | $24.42 | 2023 | Artis Q Ceiling |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.